Major Depression Clinical Trials
Depression affects millions of people worldwide every year. Together, we can work to create a world where no one has to suffer from this debilitating and often chronic illness. But we can’t do it alone. We need volunteers to participate in clinical trials in order to aid in the development of new treatments. Scroll down to learn more about the clinical trials we offer.
Moonlight-1, for patients living with Depression with continued symptoms after trying several antidepressant medications
You may qualify for this study if you are age 18-64 and diagnosed with depression before the age of 55, having a current episode of depression lasting between 2 and 24 months, and have taken 0, 1, or 2 treatments for depression in the current episode. All study-required visits, tests and medication will be provided to you. You will be compensated for your time and may also be reimbursed for study-related travel.
Participating in clinical research allows us to connect patients with innovative forms of care. Additionally, clinical research helps to advance medicine for generations to come.
Interested in volunteering for this study? Use the button below to apply, and a member of the clinical team will contact you to discuss the study further.
Patients with MDD not Responding to their Current Medication
This is a 9 week depression study for patients, age 18-65, with a diagnosis of Major Depressive Disorder who feel that their current medication is not working well. Patients must have had two antidepressant trials during the current episode. The study medication/placebo will be added to their current antidepressant. Compensation for your time is provided throughout the duration of the 9 weekly visits.
Participating in clinical research allows us to connect patients with innovative forms of care. Additionally, clinical research helps to advance medicine for generations to come.
Interested in volunteering for this study? Use the button below to apply, and a member of the clinical team will contact you to discuss the study further.
Patients with Major Depression not responding to their current medication
A 6-week double blind and 7-week open label trial of ALTO-300 for patients, age 18-70, currently experiencing a depressive episode and have an inadequate response to their current antidepressant. The study medication or placebo will be added to their current antidepressant. The visits occur every 1-4 weeks and travel is reimbursed. Participants are compensated for their time.
OARS-7, A New Treatment for Patients with Depression and Insomnia
This study is designed to evaluate the an investigational medication in people with depression, age 18-74, currently experiencing symptoms of depression while currently taking an antidepressant medication. Qualified patients may receive study-related medical care and investigational study medication at no cost. Participants will be compensated for their time. This study lasts 16 weeks or more.
An Investigational Medication for Patients with Major Depressive Disorder not Responding to their Current Antidepressant
A 14 week double blind trial of SEP-363856 (Ulotarant) for patients, age 18-65, currently experiencing a depressive episode with an inadequate response to their antidepressant. Their current antidepressant will be changed (and provided by the Sponsor) in addition to the study medication/placebo. Compensation is provided for those who qualify. Visits occur every 1-4 weeks and travel can be reimbursed with receipt.
Have questions?
Our study team would be happy to speak with you regarding any questions or concerns you may have. Visit our FAQ page or contact us today!
Let’s keep in touch
Follow us on social for the latest updates!